Skip to main content
Premium Trial:

Request an Annual Quote

Artemis to Provide Biovitrum with RNAi-modified Transgenic Mice

NEW YORK, July 7 (GenomeWeb News) - Artemis Pharmaceuticals will provide Biovitrum with RNAi-modified transgenic mice, the companies said today.

 

Under the agreement, Cologne, Germany-based Artemis will create shRNAi knock-down transgenic mice for Biovitrum of Stockholm, Sweden.

 

Biovitrum will use these mice, in which the expression of certain proteins will be down-regulated, in its pharmaceutical research programs.

The Scan

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.